Danaher Corp(DHR-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low192.14
Day High197.88
Open:197.42
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
StockStory
Danaher (DHR) Stock Is Up, What You Need To Know
DHR
StockStory
3 Healthcare Stocks with Questionable Fundamentals
DHR
Motley Fool
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?
StockStory
1 Profitable Stock with Promising Prospects and 2 That Underwhelm
COIN
Motley Fool
The Best Stocks to Invest $1,000 in Right Now
StockStory
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
AMRC
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Medline (MDLN), Danaher (DHR)
StockStory
3 Reasons to Avoid DHR and 1 Stock to Buy Instead
DHR
Zacks Investment Research
Strong Performance Continues at DHR's Biotechnology Unit: What's Next?
Strong Performance Continues at DHR's Biotechnology Unit: What's Next?
Zacks Investment Research
Everpure Jumps 34% in a Year: Should Investors Bet on the Stock?
Everpure Jumps 34% in a Year: Should Investors Bet on the Stock?
Tipranks
Danaher Completes Multi-Tranche Swiss Franc Notes Offering
Tipranks
Danaher (DHR) Initiated with a Buy at DZ BANK AG
Tipranks
Analysts Conflicted on These Healthcare Names: BeOne Medicines (ONC), Moderna (MRNA) and Danaher (DHR)
StockStory
Research Tools & Consumables Stocks Q1 Results: Benchmarking Danaher (NYSE:DHR)
DHR
Zacks Investment Research
Strength in Danaher's Biotechnology Unit Seems Firm: More Upside Ahead?
Strength in Danaher's Biotechnology Unit Seems Firm: More Upside Ahead?
Tipranks
Bank of America Securities Reaffirms Their Buy Rating on Danaher (DHR)
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Danaher Shareholders Back Directors, Pay Plan and Auditor
Tipranks
Danaher Issues Euro Notes to Finance Masimo Acquisition

Profile

Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.